Investment Firm
Overview
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Sep 03, 2020
Convertible Note
Highlights
Location
Social
SyntheX raised an undisclosed amount on 2020-09-03 in Convertible Note
SyntheX is a biotechnology company reimagining precision therapeutics with new drug discovery technologies focused on protein modulation.
Company Funding History
6
Announcment Date | Transaction Name | Number Of Investors | Lead Investor | Money Raised |
---|---|---|---|---|
Jul 27, 2022 | Convertible Note - SyntheX | 2 | - | undefined |
Dec 29, 2023 | Venture Round - SyntheX | - | 5.2M | |
Mar 01, 2017 | Seed Round - SyntheX | 4 | - | 6.2M |
Mar 10, 2016 | Convertible Note - SyntheX | 2 | - | 250.0K |
Recent Activity
There is no recent news or activity for this profile.